|
 
 |
| LETTER TO EDITOR |
|
| Year : 2022 | Volume
: 10
| Issue : 1 | Page : 49 |
|
Comment on “quality of life in patients affected by age-related macular degeneration”
Bharat Gurnani1, Kirandeep Kaur2
1 Department of Cornea and Refractive Services, Department of Pediatric Ophthalmology and Strabismus, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, India
2 Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, India
| Date of Submission | 13-Apr-2021 |
| Date of Decision | 12-Jun-2021 |
| Date of Acceptance | 12-Jun-2021 |
| Date of Web Publication | 3-Feb-2022 |
Correspondence Address:
Kirandeep Kaur
Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry - 605 007
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jcor.jcor_53_21
How to cite this article:
Gurnani B, Kaur K. Comment on “quality of life in patients affected by age-related macular degeneration”. J Clin Ophthalmol Res 2022;10:49 |
How to cite this URL:
Gurnani B, Kaur K. Comment on “quality of life in patients affected by age-related macular degeneration”. J Clin Ophthalmol Res [serial online] 2022 [cited 2023 Jun 8];10:49. Available from: https://www.jcor.in/text.asp?2022/10/1/49/337195 |
Sir,
Age-related macular degeneration (ARMD) is the third most common cause of visual impairment and accounts for approximately 8.7% of the total blindness globally.[1] For a major proportion of population, quality of life is governed by the underlying ocular comorbidity and ARMD forms a major chunk of them.[2] We read the interesting article by Palsule et al.[3] in the current issue of Journal of Clinical Ophthalmology and Research and we must congratulate the authors for bringing out a very good analysis. However, we have few important observations and suggestion to make.
First, what was the duration and time period of analysis? This is important since due to recent COVID-19 pandemic majority of the studies are at a halt. If done during the pandemic, then the COVID-19 screening protocol thermal screening, hand hygiene, sanitization, and social distancing deservers a mention in the methodology. This needs clarification.
Second, it would be interesting to know, whether only newly diagnosed ARMD patients were recruited or follow-up were also included? Another important question is about the cataract patients. Were all/any cataract patients excluded as dense cataract may pose difficulty in fundus visualization and hence the diagnosis.
Third, the authors mention that optical coherence tomography and fundus fluorescein angiography records were evaluated if any. Were all the recruited patients subjected to OCT and FFA or not, this is not clear. Kindly also clarify for readers benefit if any selection criteria was used for the same. Can the authors throw some light over this.
Finally, the studies misses few potential points which could have been added by the authors like Declaration of Helsinki, informed patient consent and use of Amsler's Grid test which a very important home monitoring tool for macular pathologies. Once again, we would like to congratulate the authors for bringing out this interesting analysis.
Acknowledgments
The authors would like to thank Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, India.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | |  |
| 1. | Kulkarni SR, Aghashe SR, Khandekar RB, Deshpande MD. Prevalence and determinants of age-related macular degeneration in the 50 years and older population: A hospital based study in Maharashtra, India. Indian J Ophthalmol 2013;61:196-201.  [ PUBMED] [Full text] |
| 2. | Schippert AC, Jelin E, Moe MC, Heiberg T, Grov EK. The Impact of Age-Related Macular Degeneration on Quality of Life and Its Association With Demographic Data: Results From the NEI VFQ-25 Questionnaire in a Norwegian Population. Gerontol Geriatr Med. 2018 Sep 20;4:2333721418801601. |
| 3. | Palsule AC, Kulkarni AA, Jathar KV. Quality of life in patients affected by age-related macular degeneration. J Clin Ophthalmol Res 2021;9:3-8. [Full text] |
|
Search Pubmed for